DOSSIER · 13F-HR · Q2 2026

ACT CAPITAL MANAGEMENT, LLC

$153M in tracked AUM across 62 positions as of Q2 2026.

AC
CIK 0001442273 · last filed Jun 30, 2026
Total AUM
$153M
as of Q2 2026
Holdings
62
positions
Whale Score
60
60
tracked
Activity
no data
changes this Q
AI Analysis · Q2 2026

ACT CAPITAL MANAGEMENT, LLC filed its latest 13F-HR for Q2 2026. See the latest holdings and position changes below.

Quarter at a glance — Q2 2026

Position-change comparison pending.

No quarter-over-quarter changes available.

Top 10 holdings

By portfolio weight as of Q2 2026.

#HoldingValueSharesWeight
01
KRYS
KRYSTAL BIOTECH INC
$17M45K10.9%
02
TGTX
TG THERAPEUTICS INC
$14M251K9.0%
03
ABVX
ABIVAX SA
$13M97K8.4%
04
CVX
CHEVRON CORP
$12M75K8.1%
05
XOM
EXXON MOBIL CORP
$11M79K7.0%
06
ARWR
ARROWHEAD PHARMACEUTICALS INC
$9M110K5.9%
07
VKTX
VIKING THERAPEUTICS INC
$8M209K5.3%
08
CELC
CELCUITY INC
$7M62K4.2%
09
NKTR
NEKTAR THERAPEUTICS
$6M89K4.1%
10
TSLA
TESLA INC
$5M11K3.0%

Filing history

2026Q2Jun 30
$153M 20.3%
62 positionsView →
2026Q1Mar 31
$127M 2.9%
56 positionsView →
2025Q4Dec 31
$124M 70.7%
59 positionsView →
2022Q3Sep 30
$72M 1.3%
71 positionsLocked
2022Q2Jun 30
$72M 24.4%
78 positionsLocked
2022Q1Mar 31
$95M 31.7%
85 positionsLocked
2021Q4Dec 31
$138M 28.3%
92 positionsLocked
2021Q3Sep 30
$193M 0.8%
108 positionsLocked
2021Q2Jun 30
$195M
117 positionsLocked